45 related articles for article (PubMed ID: 18456406)
21. Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.
Sun Y; Gao X; Liu J; Kong QY; Wang XW; Chen XY; Wang Q; Cheng YF; Qu XX; Li H
Arch Pathol Lab Med; 2011 Apr; 135(4):451-8. PubMed ID: 21466361
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of Notch pathway molecules in oral squamous cell carcinoma.
Hijioka H; Setoguchi T; Miyawaki A; Gao H; Ishida T; Komiya S; Nakamura N
Int J Oncol; 2010 Apr; 36(4):817-22. PubMed ID: 20198324
[TBL] [Abstract][Full Text] [Related]
23. Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate.
Pistollato F; Rampazzo E; Persano L; Abbadi S; Frasson C; Denaro L; D'Avella D; Panchision DM; Della Puppa A; Scienza R; Basso G
Stem Cells; 2010 Nov; 28(11):1918-29. PubMed ID: 20827750
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
Groeneweg JW; Hall TR; Zhang L; Kim M; Byron VF; Tambouret R; Sathayanrayanan S; Foster R; Rueda BR; Growdon WB
Gynecol Oncol; 2014 Jun; 133(3):607-15. PubMed ID: 24667249
[TBL] [Abstract][Full Text] [Related]
25. A study on Notch signaling in human breast cancer.
Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
[TBL] [Abstract][Full Text] [Related]
26. Correlative analyses of notch signaling with resveratrol-induced differentiation and apoptosis of human medulloblastoma cells.
Wang Q; Li H; Liu N; Chen XY; Wu ML; Zhang KL; Kong QY; Liu J
Neurosci Lett; 2008 Jun; 438(2):168-73. PubMed ID: 18456406
[TBL] [Abstract][Full Text] [Related]
27. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers.
Farooqi AA; Khalid S; Ahmad A
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495357
[TBL] [Abstract][Full Text] [Related]
29. Still puzzling Notch signaling in B-cell malignancies.
Chiaramonte R
Leuk Res; 2006 Nov; 30(11):1331-2. PubMed ID: 16934329
[No Abstract] [Full Text] [Related]
30. Notch Signaling in Cancer: Rationale and Strategies for Targeting.
Alketbi A; Attoub S
Curr Cancer Drug Targets; 2015; 15(5):364-74. PubMed ID: 26239151
[TBL] [Abstract][Full Text] [Related]
31. Notch signaling proteins: legitimate targets for cancer therapy.
Wang Z; Li Y; Sarkar FH
Curr Protein Pept Sci; 2010 Sep; 11(6):398-408. PubMed ID: 20491628
[TBL] [Abstract][Full Text] [Related]
32. Perspectives on the discovery of NOTCH2-specific inhibitors.
Dobranowski P; Ban F; Contreras-Sanz A; Cherkasov A; Black PC
Chem Biol Drug Des; 2018 Mar; 91(3):691-706. PubMed ID: 29078041
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological studies on resveratrol.
Kimura Y
Methods Find Exp Clin Pharmacol; 2003 May; 25(4):297-310. PubMed ID: 12808475
[No Abstract] [Full Text] [Related]
34. Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach.
Karthika C; Najda A; Klepacka J; Zehravi M; Akter R; Akhtar MF; Saleem A; Al-Shaeri M; Mondal B; Ashraf GM; Tagde P; Ramproshad S; Ahmad Z; Khan FS; Rahman MH
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889532
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
